Ebola in Africa: Why it's a constant threat
Ebola is highly contagious and deadly. It spreads internationally, such as in the May 2026 outbreaks in the Democratic Republic of the Congo and Uganda. But that doesn't automatically make it a pandemic.
๐ฉ๐ช ๋ ์ผ ยท "PANDEMIC" ยท ์ด 3๊ฑด
ํํฐ ๋ณด๊ธฐํ์ฌ ์ง์
50.0
0 = ๋ถ์ ์ฐ์ธ
50 = ์ค๋ฆฝ
100 = ๊ธ์ ์ฐ์ธ
์ต๊ทผ 7์ผ ๊ธฐ์ค 5,479๊ฑด์ ๋ถ์ํ ๊ฒฐ๊ณผ, ๋ด์ค ์ฌ๋ฆฌ์ง์๋ 50.0(๊ท ํ)์ ๋๋ค. ๊ธ์ 0๊ฑด(0.0%)ยท์ค๋ฆฝ 5,479๊ฑด(100.0%)ยท๋ถ์ 0๊ฑด(0.0%)์ด๋ฉฐ, ์ค๋ฆฝ ๋น์ค์ด ๋๋ ทํ๊ฒ ๋์ต๋๋ค. ์ฑํฅ ์ง์๋ ์ข ํฉ 0.0(์ค๋ ๊ท ํ)์ ๋๋ค.
Ebola is highly contagious and deadly. It spreads internationally, such as in the May 2026 outbreaks in the Democratic Republic of the Congo and Uganda. But that doesn't automatically make it a pandemic.
The Andes hantavirus outbreak shows how easily disease labels are misunderstood โ and why they describe patterns of spread, not how dangerous a virus is.
BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its founders. Can its ambitious cancer trials turn it from a one-hit wonder into a biotech giant?